Fewer people than before are being diagnosed with and dying from cancer in Appalachia, but cancer incidence and death rates remain substantially higher, especially in certain areas of Central Appalachia, compared to elsewhere in the U.S.
Freya Biosciences secures new investment to develop microbial immunotherapies for bacterial vaginosis
Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women’s health, today announces a $10.4 million strategic investment from the Bill &